Metabolic aspects of obstructive sleep apnoea syndrome

European Respiratory Review

Volumn 18, Issue 112, 2009, Pages 113-124

  Bonsignore, M R ^a,b   Eckel, J ^b,c  

^a UNIVERSITY OF PALERMO   (Italy)

^b CNR Consiglio Nazionale delle Ricerche   (Italy)

^c LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

Adipokines; Adipose tissue; Hypoxia; Inflammation; Insulin resistance; Treatment

Indexed keywords

ADIPOCYTOKINE; ENDOCANNABINOID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; RIMONABANT;

ADIPOCYTE; ADIPOSE TISSUE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CELL FUNCTION; COMORBIDITY; CONFERENCE PAPER; DAYTIME SOMNOLENCE; DISEASE ASSOCIATION; DRUG MECHANISM; GLUCOSE METABOLISM; HORMONE RESPONSE; HUMAN; HYPOXIA; INFLAMMATION; INSOMNIA; INSULIN RESISTANCE; MEDICAL RESEARCH; MEDICAL SOCIETY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; POSITIVE END EXPIRATORY PRESSURE; SKELETAL MUSCLE; SLEEP APNEA SYNDROME; SLEEP DEPRIVATION; UNSPECIFIED SIDE EFFECT; ANIMAL; DIAPHRAGM PARALYSIS; METABOLISM; PATHOLOGY; SHEEP; SHEEP DISEASE;

ADIPOSE TISSUE; ANIMALS; HUMANS; OBESITY; RESPIRATORY PARALYSIS; SHEEP; SHEEP DISEASES;

EID: 66549104099     PISSN: 09059180     EISSN: None     Source Type: Journal    
DOI: 10.1183/09059180.00000109     Document Type: Conference Paper

References (134)

1. COST. European Cooperation in Science and Technology www.cost.esf.org
2. Young T, Peppard PE, Taheri S. Excess weight and sleep-disordered breathing. J Appl Physiol 2005; 99: 1592-1599. (Pubitemid 43014371)
3. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. WHO Technical Report Series 894. Geneva, World Health Organization, 2000.
4. Kelly A, Marcus CL. Childhood obesity, inflammation, and apnea. What is the future for our children? Am J Respir Crit Care Med 2005; 171: 202-203.
5. Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365: 1046-1053. (Pubitemid 40386782)
6. Buchner NJ, Sanner BM, Borgel J, et al. Continuous positive airway pressure treatment of mild to moderate obstructive sleep apnea reduces cardiovascular risk. Am J Respir Crit Care Med 2007; 176: 1274-1280. (Pubitemid 350256482)
7. Drager LF, Bortolotto LA, Lorenzi MC, et al. Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2005; 172: 613-618. (Pubitemid 41232973)
8. Peker Y, Carlson J, Hedner J. Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J 2006; 28: 596-602. (Pubitemid 44794676)
9. McNicholas WT, Bonsignore MR, Management Committee of the EU COST ACTION B26. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 2007; 29: 156-178.
10. Rosen ED, Spiegelman BM. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 2006; 444: 847-853. (Pubitemid 46024991)
11. Spiegel K, Knutson K, Leproult K, et al. Sleep loss: a novel risk factor for insulin resistance and type 2 diabetes. J Appl Physiol 2005; 99: 2008-2019. (Pubitemid 41547204)
12. Ford ES. Risk for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome. Diab Care 2005; 28: 1769-1778.
13. Kahn R. Metabolic syndrome: is it a syndrome? Does it matter? Circulation 2007; 115: 1806-1811.
14. Beaser RS, Levy P. A work in progress, but a useful construct. Circulation 2007; 115: 1812-1818.
15. Despréemieux I. Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881-887. (Pubitemid 46024995)
16. World Health Organization. Definition, diagnosis, and classification of diabetes mellitus and its complications. Report of a WHO Consultation. Geneva, World Health Organization, 1999.
17. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752.
18. Alberti KG, Zimmer P, Shaw J, et al. The metabolic syndrome: a new worldwide definition. Lancet 2005; 366: 1059-1062. (Pubitemid 41338752)
19. Punjabi NM, Ahmed MM, Polotsky VY, et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance. Respir Physiol Neurobiol 2003; 136: 167-178. (Pubitemid 36809004)
20. Lam JCM, Lam B, Lam C-L, et al. Obstructive sleep apnea and the metabolic syndrome in community-based Chinese adults in Hong Kong. Respir Med 2006; 100: 980-987.
21. Sasanabe R, Banno K, Otake K, et al. Metabolic syndrome in Japanese patients with obstructive sleep apnea syndrome. Hypertens Res 2006; 29: 315-322. (Pubitemid 43965112)
22. Kono M, Tatsumi K, Saibara T, et al. Obstructive sleep apnea syndrome is associated with some component of metabolic syndrome. Chest 2007; 131: 1387-1392. (Pubitemid 46762343)
23. Ip MS, Lam B, Ng MM, et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002; 165: 670-676. (Pubitemid 34194755)
24. Harsch IA, Schahin SP, Radespiel-Troger M, et al. Continuous positive airway pressure treatment rapidly improves insulin sensivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004; 169: 156-162. (Pubitemid 38114528)
25. Davies RJ, Turner R, Crosby J, et al. Plasma insulin and lipid levels in untreated obstructive sleep apnea and snoring; their comparison with matched controls and response to treatment. J Sleep Res 1994; 3: 180-185. (Pubitemid 24311373)
26. Barcelò A, Barbè F, Llompart E, et al. Effects of obesity on C-reactive protein level and metabolic disturbances in male patients with obstructive sleep apnea. Am J Med 2004; 15: 118-121.
27. Gruber A, Horwood F, Sithole J, et al. Obstructive sleep apnea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovasc Diabetol 2006; 5: 22-29. (Pubitemid 44781864)
28. Reichmuth KJ, Austin D, Skatrud JB, et al. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med 2005; 172: 1590-1595. (Pubitemid 43076551)
29. West SD, Nicoll DJ, Wallace TM, et al. Effect of CPAP on insulin resistance andHbA1c inmenwith obstructive sleep apnoea and type 2 diabetes. Thorax 2007; 62: 969-974. (Pubitemid 350084496)
30. Coughlin SR, Mawdsley L, Mugarza JA, et al. Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur Respir J 2007; 29: 720-727. (Pubitemid 46554622)
31. Oltmanns KM, Gehring H, Rudolf S, et al. Hypoxia causes glucose intolerance in humans. Am J Respir Crit Care Med 2004; 169: 1231-1237. (Pubitemid 38680401)
32. Iyiori N, Alonso LC, Li J, et al. Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir Crit Care Med 2007; 175: 851-857. (Pubitemid 46631798)
33. Ye J, Gao Z, Yin J, et al. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 2007; 293: E1118-E1128. (Pubitemid 47535846)
34. Hosogai N, Fukuhara A, Oshima K, et al. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 2007; 56: 901-911. (Pubitemid 46525054)
35. Chen B, Lam KS, Wang Y, et al. Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes. BiochemBiophys ResCommun 2006; 341: 549-556. (Pubitemid 43152139)
36. Coughlin SR, Mawdsley L, Mugarza JA, et al. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004; 25: 735-741. (Pubitemid 38647933)
37. Vgontzas AN, Bixler EO, Chrousos GP. Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance. J Intern Med 2003; 254: 32-44. (Pubitemid 36819129)
38. Chin K, Shimizu K, Nakamura T, et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 1999; 100: 706-712. (Pubitemid 29383639)
39. Knutson KL, Spiegel K, Penev P, et al. The metabolic consequences of sleep deprivation. Sleep Med Rev 2007; 11: 163-178. (Pubitemid 46778995)
40. Spiegel K, Leproult R, L'Hermite-Balériaux M, et al. Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 2004; 141: 846-850. (Pubitemid 39601178)
41. Taheri S, Lin L, Austin D, et al. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med 2004; e62. (Pubitemid 40418884)
42. Hasler G, Buysse DJ, Klaghofer R, et al. The association between short sleep duration and obesity in young adults: a 13-year prospective study. Sleep 2004; 27: 661-666. (Pubitemid 38823362)
43. Tasali E, Leproult R, Ehrmann DA, et al. Slow-wave sleep and the risk of type 2 diabetes in humans. Proc Natl Acad Sci USA 2008; 105: 1044-1049.
44. Vgontzas AN, Zoumakis E, Bixler EO, et al. Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab 2004; 89: 2119-2126. (Pubitemid 38619840)
45. Haack M, Sanchez E, Mullington JM. Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers. Sleep 2007; 30: 1145-1152. (Pubitemid 47378957)
46. Irwin MR, Wang M, Campomayor CO, et al. Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med 2006; 166: 1756-1762. (Pubitemid 44414465)
47. Irwin M, Thompson J, Miller C, et al. Effects of sleep and sleep deprivation on catecholamine and interleukin-2 levels in humans: clinical implications. J Clin Endocrinol Metab 1999; 84: 1979-1985. (Pubitemid 30647021)
48. Johnson JD, Campisi J, Sharkey CM, et al. Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience 2005; 135: 1295-1307. (Pubitemid 41416690)
49. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report on the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-3221.
50. Wilcox I, McNamara SG, Collins FL, et al. "Syndrome Z": the interaction of sleep apnoea, vascular risk factors and heart disease. Thorax 1998; 53: Suppl. 3, S25-S28.
51. Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997; 82: 1313-1316. (Pubitemid 27200394)
52. Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000; 85: 1151-1158. (Pubitemid 32269364)
53. Vgontzas AN, Legro RS, Bixler EO, et al. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metab 2001; 86: 517-520. (Pubitemid 32207453)
54. Bixler EO, Vgontzas AN, Lin HM, et al. Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes and depression. J Clin Endocrinol Metab 2005; 90: 4510-4515. (Pubitemid 41159334)
55. Bixler EO, Vgontzas AN, Lin HM, et al. Prevalence of sleep-disordered breathing in women. Am J Respir Crit Care Med 2001; 163: 608-613.
56. Li C, Ford ES, McGuire LC, et al. Increasing trends in waist circumference and abdominal obesity among US adults. Obesity 2007; 15: 216-224. (Pubitemid 46219802)
57. Lobstein T, Jackson-Leach R. Estimated burden of paediatric obesity and co-morbidities in Europe. Part 2. Numbers of children with indicators of obesity-related disease. Int J Pediatr Obes 2006; 1: 33-41.
58. Körner A, Blüher S, Kapellen T, et al. Obesity in childhood and adolescence: a review in the interface between adipocyte physiology and clinical challenges. Hormones (Athens) 2005; 4: 189-199.
59. Gupta NK, Mueller WH, Chan W, et al. Is obesity associated with poor sleep quality in adolescents? Am J Hum Biol 2002; 14: 762-768.
60. Sekine M, Yamagami T, Handa K, et al. A dose-response relationship between short sleeping hours and childhood obesity: results of the Toyama Birth Cohort Study. Child Care Health Dev 2002; 28: 163-170. (Pubitemid 34812335)
61. Von Kries R, Toschke AM, Wurmser H, et al. Reduced risk for overweight and obesity in 5- and 6-y-old children by duration of sleep-a cross-sectional study. Int J Obes Relat Metab Disord 2002; 26: 710-716. (Pubitemid 34499292)
62. Verhulst SL, Schrauwen N, Haentjens D, et al. Sleep-disordered breathing in overweight and obese children and adolescents: prevalence, characteristics and the role of fat distribution. Arch Dis Child 2007; 92: 205-208. (Pubitemid 46423787)
63. Verhulst SL, Schrauwen N, Haentjens NSD, et al. Sleep-disordered breathing and the metabolic syndrome in overweight and obese children and adolescents. J Pediatr 2007; 150: 608-612. (Pubitemid 46755804)
64. Verhulst SL, van Hoeck K, Schrauwen N, et al. Sleep-disordered breathing and uric acid in overweight and obese children and adolescents. Chest 2007; 132: 76-80. (Pubitemid 47068206)
65. Kheirandish-Gozal L, Capdevila OS, Kheirandish E, et al. Elevated serum aminotransferase levels in children at risk for obstructive sleep apnea. Chest 2008; 133: 92-99.
66. Flint J, Kothare SV, Zihlif M, et al. Association between inadequate sleep and insulin resistance in obese children. J Pediatrics 2007; 150: 364-369. (Pubitemid 46428289)
67. Sell H, Eckel J. Monocyte chemotactic protein-1 and its role in insulin resistance. Curr Opin Lipidol 2007; 18: 258-262. (Pubitemid 46743048)
68. Trayhurn P, Wang B, Wood S. Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity? Br J Nutr 2008; 100: 227-235.
69. Zhang Y, Proenca P, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432. (Pubitemid 24365442)
70. Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 2001; 60: 329-339. (Pubitemid 32772448)
71. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112: 1821-1830. (Pubitemid 38063705)
72. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004; 92: 347-355. (Pubitemid 40277057)
73. Rocha S. Gene regulation under low oxygen: holding your breath for transcription. Trends Biochem Sci 2007; 32: 389-397. (Pubitemid 47126857)
74. Sell H, Dietze-Schroeder D, Eckel J. The adipocytemyocyte axis in insulin resistance. Trends Endocrinol Metab 2006; 17: 416-422.
75. Dietze D, Koenen M, Röhrig K, et al. Impairment of insulin signaling in human skeletal muscle cells by coculture with human adipocytes. Diabetes 2002; 51: 2369-2376. (Pubitemid 34827384)
76. Sartipy P, Loskutoff DJ. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci USA 2003; 100: 7265-7270. (Pubitemid 36706427)
77. Shoelson SE, Lee J, Yuan M. Inflammation and the IKK beta/IKB/NF-kB axis in obesity- and diet-induced insulin resistance. Int J Obes Relat Metab Disord 2003; 27: Suppl. 3, S49-S52.
78. Després JP. The endocannabinoid system: a new target for the regulation of energy balance and metabolism. Crit Pathw Cardiol 2007; 6: 46-50. (Pubitemid 46878231)
79. Muller JE, Tofler GH. Circadian variation and cardiovascular disease. N Engl J Med 1991; 325: 1038-1039.
80. Reilly DF, Westgate EJ, FitzGerald GA. Peripheral circadian clocks in the vasculature. Arterioscler Thromb Vasc Biol 2007; 27: 1694-1705. (Pubitemid 47207164)
81. Hastings M, O'Neill JS, Maywood ES. Circadian clocks: regulators of endocrine and metabolic rhythms. J Endocrinol 2007; 195: 187-198. (Pubitemid 350143100)
82. Turek FW, Joshu C, Kohsaka A, et al. Obesity and the metabolic syndrome in circadian Clock mutant mice. Science 2005; 308: 1043-1045. (Pubitemid 40664419)
83. Green CB, Douris N, Kojima S, et al. Loss of nocturnin, a circadian deadenylase, confers resistance to hepatic steatosis and diet-induced obesity. Proc Natl Acad Sci USA 2007; 104: 9888-9893. (Pubitemid 47175361)
84. Gilde AJ, Fruchart J-C, Staels B. Peroxisome proliferated-activated receptors at the crossroads of obesity, diabetes and cardiovascular disease. J Am Coll Cardiol 2006; 48: A24-A32. (Pubitemid 44648644)
85. Sharma AM, Staels B. Peroxisome proliferator-activated receptor-c and adipose tissue. Understanding obesity-related changes in regulation of lipid and glucose metabolism. J Clin Endocrinol Metab 2007; 92: 386-395. (Pubitemid 46255265)
86. Barbier O, Pineda Torra I, et al. Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis. Arterioscl Thromb Vasc Biol 2002; 22: 717-726. (Pubitemid 34517781)
87. Marx N, Duez H, Fruchart J-C, et al. Peroxisome proliferated-activated receptors and atherogenesis. Regulators of gene expression in vascular cells. Circ Res 2004; 94: 1168-1178.
88. Chinetti G, Fruchart JC, Staels B. Transcriptional regulation of macrophage cholesterol trafficking by PPARa and LXR. Biochem Soc Trans 2006; 34: 1128-1131. (Pubitemid 46769003)
89. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007; 117: 175-184. (Pubitemid 46048464)
90. Bouhlel MA, Derudas B, Rigamonti E, et al. PPAR-gamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab 2007; 6: 137-143. (Pubitemid 47189091)
91. Cases JA, Barzilai N. The regulation of body fat distribution and the modulation of insulin action. Int J Obes Relat Metab Disord 2000; 24: Suppl. 4, S63-S66.
92. Giorgino F, Laviola L, Eriksson JW. Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies. Acta Physiol Scand 2005; 183: 13-30. (Pubitemid 40188033)
93. Pi-Sunyer FX, Aronne LJ, Heshmati HM, et al. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA 2006; 295: 761-775. (Pubitemid 43244304)
94. Van Gaal LF, Rissanen AM, Scheen AJ, et al. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 2005; 365: 1389-1397. (Pubitemid 40523733)
95. Després JP, Golay A, Sjö strömL, et al. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med 2005; 353: 2121-2134. (Pubitemid 41653104)
96. Scheen AJ, Finer N, Hollander P, et al. Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study. Lancet 2006; 368: 1660-1672. (Pubitemid 46048528)
97. Hansson GK. Inflammation, atherosclerosis and coronary artery disease. N Engl J Med 2005; 352: 1685-1695.
98. Vasan RS. Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation 2006; 113: 2335-2362. (Pubitemid 43947980)
99. Ohga, E, Tomita T, Wada H, et al. Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol 2003; 94: 179-184. (Pubitemid 36014310)
100. Ryan S, Taylor CT, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 2005; 112: 2660-2667. (Pubitemid 41532603)
101. Ryan S, Taylor CT, McNicholas WT. Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2006; 174: 824-830. (Pubitemid 44511665)
102. Yokoe, T, Minoguchi K, Matsuo H, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003; 107: 1129-1134. (Pubitemid 36297204)
103. Drager LF, Bortolotto LA, Figueiredo AC, et al. Effects of CPAP on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2007; 176: 706-712.
104. Ryan SM, McNicholas WT, Taylor CT. A critical role for P38-MAP kinase in NFkB signaling during intermittent hypoxia/reoxygenation. Biochem Biophys Res Commun 2007; 355: 728-733. (Pubitemid 46330212)
105. Greenberg H, Ye X, Wilson D, et al. Chronic intermittent hypoxia activates nuclear factor-kB in cardiovascular tissues in vivo. Biochem Biophys Res Commun 2006; 343: 591-598.
106. Htoo AK, Greenberg H, Tongia S, et al. Activation of nuclear factor-kB in obstructive sleep apnea: a pathway leading to systemic inflammation. Sleep Breath 2006; 10: 43-50. (Pubitemid 44193436)
107. Ip MS, Tse HF, Lam B, et al. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 2004; 169: 348-353. (Pubitemid 38134813)
108. Huang LE, Bunn HF. Hypoxia-inducible factor and its biomedical relevance. J Biol Chem 2003; 278: 19575-19578. (Pubitemid 36799137)
109. Semenza GL, PrabhakarNR. HIF-1-dependent respiratory, cardiovascular, and redox responses to chronic intermittent hypoxia. Antioxid Redox Signal 2007; 9: 1391-1396.
110. Peng YJ, Yuan G, Ramakrishnan D, et al. Heterozygous HIF-1α deficiency impairs carotid body-mediated systemic responses and reactive oxygen species generation in mice exposedto intermittenthypoxia. JPhysiol 2006; 577: 705-716. (Pubitemid 44804021)
111. Bonello S, Zähringer C, Bel Aiba RS, et al. Reactive oxygen species activate the HIF-1α promoter via a functional NFκB site. Arterioscler Thromb Vasc Biol 2007; 27: 755-761. (Pubitemid 46606703)
112. Haack M, Sanchez E, Mullington JM. Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers. Sleep 2007; 30: 1145-1152. (Pubitemid 47378957)
113. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006; 116: 1793-1801.
114. Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 2002; 165: 934-939. (Pubitemid 34774660)
115. Lavie L. Obstructive sleep apnoea syndrome - an oxidative stress disorder. Sleep Med Rev 2003; 7: 35-51. (Pubitemid 36188305)
116. Dyugovskaya L, Polyakov A, Lavie P, et al. Delayed neutrophil apoptosis in sleep apnea patients. Am J Respir Crit Care Med 2008; 177: 544-554.
117. Walmsley SR, Print C, Farahi N, et al. Hypoxia-induced neutrophil survival is mediated by HIF-1α-dependent NFκB activity. J Exper Med 2005; 201: 105-115. (Pubitemid 40130088)
118. Dyugovskaya L, Lavie P, Lavie L. Phenotypic and functional characterization of blood cd T cells in sleep apnea. Am J Respir Crit Care Med 2003; 168: 242-249.
119. Vgontzas AN, Bixler EO, Tan TL, et al. Obesity without sleep apnea is associated with daytime sleepiness. Arch Intern Med 1998; 158: 1333-1337. (Pubitemid 28287527)
120. Resta O, Foschino-Barbaro MP, Legari G, et al. Sleep-related breathing disorders, loud snoring and excessive daytime sleepiness in obese subjects. Int J Obes Relat Metab Disord 2001; 25: 669-675. (Pubitemid 32417636)
121. Resta O, Foschino Barbaro MP, Bonfitto P, et al. Low sleep quality and daytime sleepiness in obese patients without obstructive sleep apnoea syndrome. J Intern Med 2003; 253: 536-543. (Pubitemid 36543293)
122. Jenkins JB, Omori T, Guan Z, et al. Sleep is increased in mice with obesity induced by high-fat food. Physiol Behav 2006; 87: 255-262. (Pubitemid 43188821)
123. Vorona RD, Winn MP, Babineau TW, et al. Overweight and obese patients in a primary care population report less sleep than patients with a normal body mass index. Arch Intern Med 2005; 165: 25-30. (Pubitemid 40096078)
124. Vgontzas AN, Legro RS, Bixler EO, et al. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metab 2001; 86: 517-520. (Pubitemid 32207453)
125. Vgontzas AN, Bixler EO, Chrousos GP. Obesity-related sleepiness and fatigue. The role of the stress system and cytokines. Ann NY Acad Sci 2006; 1083: 329-344.
126. Basta M, Chrousos GP, Vela-Bueno A, et al. Chronic insomnia and stress system. Sleep Med Clin 2007; 2: 279-291.
127. Vgontzas AN, Pejovic S, Zoumakis E, et al. Hypothalamic-pituitary-adrenal axis activity in obese men with and without sleep apnea: effects of continuous positive airway pressure therapy. J Clin Endocrinol Metab 2007; 9: 4199-4207. (Pubitemid 350074732)
128. Carlson JT, Hedner J, Elam M, et al. Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest 103, 1763-1768: 1993. (Pubitemid 23174312)
129. Semenkovich CF. Insulin resistance and atherosclerosis. J Clin Invest 2006; 116: 1813-1822. (Pubitemid 44033301)
130. Goossens GH. The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol Behav 2008; 94: 206-218.
131. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-867.
132. Polotsky VY, Li J, Punjabi NM, et al. Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol 2003; 552: 253-264. (Pubitemid 37265483)
133. Li J, Thorne LN, Punjabi NM, et al. Intermittent hypoxia induces hyperlipidemia in lean mice. Circ Res 2005; 97: 698-706. (Pubitemid 41416339)
134. Li J, Savransky V, Nanayakkara A, et al. Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia. J Appl Physiol 2007; 102: 557-563. (Pubitemid 46220883)